Sarah Popek, MD | |
2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 | |
(505) 272-6901 | |
Not Available |
Full Name | Sarah Popek |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639342678 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 80924 (Arizona) | Secondary |
208600000X | Surgery | A103391 (California) | Secondary |
208C00000X | Colon & Rectal Surgery | MD2013-0865 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sarah Popek, MD 933 Bradbury Dr Se, Suite 2222, Albuquerque, NM 87106-4374 Ph: (505) 272-3120 | Sarah Popek, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 Ph: (505) 272-6901 |
News Archive
These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic development and the formation of different cell types, regulating when and where genes are switched on.
Sports medicine physician Steve Watts says cardiac screening for young athletes is useful in preventing sudden cardiac death and suggests new diagnostics have the potential to add value and change the debate about the viability of cardiac screening for young athletes in the United States.
Some people grow out of their childhood attention-deficit/hyperactivity disorder (ADHD) and some don't. In fact, around 50% of individuals diagnosed as children continue to suffer from ADHD as adults.
UT Southwestern Medical Center is the first site in North Texas to launch the next generation in CT scanners, which allow doctors to image an entire organ in less than a second or track blood flow through the brain or to a tumor - all with less radiation exposure to patients.
NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.
› Verified 8 days ago